Search results for: 'm9de fuels develop deceleration'

02 Jun 2021  |  North America  |  Market Research

Global Benchmarking of Select Cities and their Data and Digital Strategies, 2021

Cities with a Well-structured Digital Strategy will be able to Dramatically Enhance Livability

Infographics

×

Digitization is the bedrock of new technology and services expansion, new mobility solutions, and smart applications in city management. Its purview extends across a city’s digital performance and digital strategy. In terms of digital performance, this measures how a city fares in terms of smartphone penetration, 4G coverage and speed, its 5G outlo...

Indonesia is a prominent data center colocation services market in Southeast Asia. With increasing implementation of digital transformation initiatives, favorable government policies toward digital technology adoption, and improvements in the countrys connectivity and network infrastructure, the market is expected to continue growing. Enterprises a...

Although the Internet of Things (IoT) has been a buzzword for a long time, its penetration in the analytical instrumentation market has been limited when compared to other industrial markets. With key end users in the pharmaceuticals, food and beverage, and government sectors, the market proceeds with great caution (in terms of technology) as it de...

This study provides an overview of the space force capacity structure of the Asia-Pacific. With an increase in tensions and conflict zones across the globe, military space capabilities have expanded to anticipate threats, respond to crises, and project power, guiding the development of offensive and defensive strategies vital to national interests....

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

12 Sep 2023  |  Global  |  Technology Research

Growth Opportunities and Impact of Sensors and Digital Technologies on Building Automation

The Need to Improve Indoor Air Quality, Occupancy Sensing, and AI and Digital Twin are Driving Building Automation Market Growth.

Infographics

×

Building automation is increasingly relying on sensor technologies and digital services. Buildings use sensors to gather information based on a range of operational and environmental factors, including temperature, humidity, light levels, occupancy, and energy. The information can be utilized to improve building performance in a variety of ways, in...

Our society's approach to producing, consuming, and distributing energy is changing due to mounting concerns about global warming and rising CO2 levels in the atmosphere. Governments worldwide are formulating regulatory frameworks, increasing their investments in low-carbon technologies to slow climate change, and decarbonizing their economies. An ...

Changing regulatory landscapes significantly impact the chemical industry s evolution in technological advancement, product development, vertical integration, and consolidation activities. In a recent Frost & Sullivan report titled The Impact of Regulations on the Chemical Industry (PE52), we found that one of the key areas of regulation is in P...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...